Chlornicol Uses

Was this medicine useful for you?
sponsored

What is Chlornicol?

Chlornicol belongs to the family of medicines called antibiotics. Chlornicol ophthalmic preparations are used to treat infections of the eye. Chlornicol may be given alone or with other medicines that are taken by mouth for eye infections.

Chlornicol is available only with your doctor's prescription.

Chlornicol indications

sponsored

Chlornicol should be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. Bacteriological studies should be performed to determine the causative organisms and their sensitivity to Chlornicol.

Chlornicol, 1% (Chlornicol Ophthalmic Ointment, USP) is indicated for the treatment of surface ocular infections involving the conjunctiva and/or cornea caused by Chlornicol-susceptible organisms.

The particular antiinfective drug in this product is active against the following common bacterial eye pathogens:

Staphylococcus aureus

Streptococcus, including Streptococcus pneumoniae

Escherichia coli

Haemophilus influenzae

Klebsiella/Enterobacter species

Moraxella lucunata

(Morax-Axenfeld bacillus)

Neisseria species

This product does not provide adequate coverage against:

Pseudomonas aeruginosa

Serratia marcescens

How should I use Chlornicol?

Use Chlornicol as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Chlornicol.

Uses of Chlornicol in details

sponsored

Use: Labeled Indications

Serious infections: Treatment of serious infections, including cystic fibrosis exacerbations, bacterial meningitis, and bacteremia, caused by Chlamydiaceae, Haemophilus influenzae, Rickettsia, Salmonella spp. (acute infections), and other organisms when other less toxic agents are ineffective or contraindicated.

Guideline recommendations: Chlornicol may be considered for use as an alternative agent to doxycycline in the treatment of tickborne rickettsial diseases (eg, Rocky Mountain spotted fever [RMSF]); however, epidemiologic studies suggest that Chlornicol-treated patients with RMSF are at a higher risk of death compared to tetracycline-treated patients. In addition, Chlornicol is not effective in the treatment of human ehrlichiosis or anaplasmosis, therefore, use with caution in the empiric treatment of tickborne rickettsial diseases (CDC [Biggs 2016]).

Chlornicol description

Each 100 g contains Chloramphenicol 1 g.

Chlornicol dosage

sponsored

Chlornicol Dosage

Generic name: Chlornicol

Dosage form: ophthalmic ointment

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

A small amount of ointment placed in the lower conjunctival sac every three hours, or more frequently if deemed advisable by the prescribing physician. Administration should be continued day and night the first 48 hours, after which the interval between applications may be increased. Treatment should be continued for at least 48 hours after the eye appears normal.

More about Chloromycetin Ophthalmic (Chlornicol ophthalmic)

Consumer resources

Professional resources

Other formulations

Chlornicol interactions

sponsored

Alcohol (Ethyl): Chlornicol (Systemic) may enhance the adverse/toxic effect of Alcohol (Ethyl). Monitor therapy

Barbiturates: Chlornicol (Systemic) may decrease the metabolism of Barbiturates. Barbiturates may increase the metabolism of Chlornicol (Systemic). Monitor therapy

BCG (Intravesical): Antibiotics may diminish the therapeutic effect of BCG (Intravesical). Avoid combination

BCG (Intravesical): Myelosuppressive Agents may diminish the therapeutic effect of BCG (Intravesical). Avoid combination

BCG Vaccine (Immunization): Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). Monitor therapy

Carbocisteine: Chlornicol (Systemic) may enhance the adverse/toxic effect of Carbocisteine. Specifically, Chlornicol may enhance adverse effects of alcohol that is present in liquid formulations of carbocisteine-containing products. Monitor therapy

CefTAZidime: Chlornicol (Systemic) may diminish the therapeutic effect of CefTAZidime. Management: Consider using a different combination of antimicrobials, especially if bactericidal activity is desired. If these agents are combined, monitor for reduced antimicrobial effectiveness and/or therapeutic failure. Consider therapy modification

Chlornicol (Ophthalmic): May enhance the adverse/toxic effect of Myelosuppressive Agents. Monitor therapy

Cholera Vaccine: Antibiotics may diminish the therapeutic effect of Cholera Vaccine. Management: Avoid cholera vaccine in patients receiving systemic antibiotics, and within 14 days following the use of oral or parenteral antibiotics. Avoid combination

Cladribine: May enhance the myelosuppressive effect of Myelosuppressive Agents. Avoid combination

CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for neutropenia may be increased. Monitor therapy

CycloSPORINE (Systemic): Chlornicol (Systemic) may increase the serum concentration of CycloSPORINE (Systemic). Management: Cyclosporine dose reductions will likely be required with initiation of concurrent Chlornicol. Monitor cyclosporine concentrations and response closely following initiation and/or discontinuation of Chlornicol. Consider therapy modification

Deferiprone: Myelosuppressive Agents may enhance the neutropenic effect of Deferiprone. Management: Avoid the concomitant use of deferiprone and myelosuppressive agents whenever possible. If this combination cannot be avoided, monitor the absolute neutrophil count more closely. Consider therapy modification

Dipyrone: May enhance the adverse/toxic effect of Myelosuppressive Agents. Specifically, the risk for agranulocytosis and pancytopenia may be increased Avoid combination

Fosphenytoin: May decrease the serum concentration of Chlornicol (Systemic). Fosphenytoin may increase the serum concentration of Chlornicol (Systemic). Chlornicol (Systemic) may increase the serum concentration of Fosphenytoin. Monitor therapy

Lactobacillus and Estriol: Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. Monitor therapy

Mesalamine: May enhance the myelosuppressive effect of Myelosuppressive Agents. Monitor therapy

Phenytoin: May decrease the serum concentration of Chlornicol (Systemic). Phenytoin may increase the serum concentration of Chlornicol (Systemic). Chlornicol (Systemic) may increase the serum concentration of Phenytoin. Monitor therapy

Promazine: May enhance the myelosuppressive effect of Myelosuppressive Agents. Monitor therapy

RifAMPin: May increase the metabolism of Chlornicol (Systemic). Monitor therapy

Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate. Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic. Consider therapy modification

Sulfonylureas: Chlornicol (Systemic) may decrease the metabolism of Sulfonylureas. Monitor therapy

Tacrolimus (Systemic): Chlornicol (Systemic) may increase the serum concentration of Tacrolimus (Systemic). Management: Tacrolimus dose reductions will likely be required with initiation of concurrent Chlornicol. Monitor tacrolimus concentrations and response closely following initiation and/or discontinuation of Chlornicol. Consider therapy modification

Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected. Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents. Use of this vaccine should be postponed until at least 3 days after cessation of antibacterial agents. Consider therapy modification

Vitamin B12: Chlornicol (Systemic) may diminish the therapeutic effect of Vitamin B12. Monitor therapy

Vitamin K Antagonists (eg, warfarin): Chlornicol (Systemic) may enhance the anticoagulant effect of Vitamin K Antagonists. Chlornicol (Systemic) may increase the serum concentration of Vitamin K Antagonists. Monitor therapy

Voriconazole: Chlornicol (Systemic) may increase the serum concentration of Voriconazole. Monitor therapy

Chlornicol side effects

See also:
What are the possible side effects of Chlornicol?

Applies to Chlornicol: capsule, powder for solution, suspension

In addition to its needed effects, some unwanted effects may be caused by Chlornicol (the active ingredient contained in Chlornicol). In the event that any of these side effects do occur, they may require medical attention.

Stop taking Chlornicol and get emergency help immediately if any of the following effects occur:

Rare - in babies only

Major Side Effects

You should check with your doctor immediately if any of these side effects occur when taking Chlornicol:

Less common:

Rare

Minor Side Effects

Some of the side effects that can occur with Chlornicol may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

Less common:

Chlornicol contraindications

See also:
What is the most important information I should know about Chlornicol?

Chlornicol Lotion is contraindicated for premature neonates because their skin may be more permeable than full term infants and their liver enzymes may not be sufficiently developed. It is also contraindicated for patients with Norwegian (crusted) scabies due to possible increased absorption. It is also contraindicated for patients with known seizure disorders and for individuals with a known sensitivity to the product or any of its components.

Active ingredient matches for Chlornicol:

Chloramphenicol in South Africa.


List of Chlornicol substitutes (brand and generic names)

Sort by popularity
Unit description / dosage (Manufacturer)Price, USD
Chlormycin / Kingdom 250 mg x 1000's
CHLORO SS Injection / 1gm / 1 units (Lyka Hetro Labs)$ 0.42
Chloro-S 500 mg x 100's (Medic+Aid)$ 18.60
Chloro-S 125 mg/5 mL x 60 mL (Medic+Aid)$ 1.29
Chloro-S cap 500 mg 100's (Medic+Aid)$ 18.60
Chloro-S oral susp 125 mg/5 mL 60 mL x 1's (Medic+Aid)$ 1.29
Chloro-V 5 mg/1 mL x 5 mL (Vista Pharma)
Chloro-V ear drops 5 mg/mL 5 mL x 1's (Vista Pharma)
Chlorocaire 125 mg/5 mL x 60 mL
Chlorocap 500 mg Capsule (Pharma Synth Formulations Ltd.)$ 0.04
Chlorocap 250 mg Capsule (Pharma Synth Formulations Ltd.)$ 0.02
CHLOROCAP 500MG CAPSULE 1 strip / 10 capsules each (Pharma Synth Formulations Ltd.)$ 0.70
Chlorocap 500mg Capsule (Pharma Synth Formulations Ltd.)$ 0.07
CHLOROCEPT 250MG TABLET 1 strip / 10 tablets each (Concept Pharmaceuticals Ltd)$ 0.12
CHLOROCEPT SUSPENSION 1 bottle / 60 ML suspension each (Concept Pharmaceuticals Ltd)$ 0.25
CHLOROCEPT TABLET 1 packet / 250 tablets each (Concept Pharmaceuticals Ltd)$ 2.45
Chlorocept NA Suspension (Concept Pharmaceuticals Ltd)$ 0.25
Chlorocept 250mg Tablet (Concept Pharmaceuticals Ltd)$ 0.01
CHLOROCIN Capsule/ Tablet / 250mg / 10 units (Jagsonpal Pharmaceuticals Ltd)$ 0.24
CHLOROCIN Liquid / 125mg per 5ml / 60ml units (Jagsonpal Pharmaceuticals Ltd)$ 0.28
CHLOROCIN Capsule/ Tablet / 250mg / 100 units (Jagsonpal Pharmaceuticals Ltd)$ 1.20
CHLOROCIN Liquid / 125mg per 5ml / 450ml units (Jagsonpal Pharmaceuticals Ltd)$ 1.20
CHLOROCIN Capsule/ Tablet / 500mg / 10 units (Jagsonpal Pharmaceuticals Ltd)$ 0.43
Chlorocin 250mg CAP / 10 (Jagsonpal Pharmaceuticals Ltd)$ 0.24
Chlorocin 250mg CAP / 100 (Jagsonpal Pharmaceuticals Ltd)$ 1.20
Chlorocin 500mg CAP / 10 (Jagsonpal Pharmaceuticals Ltd)
Chlorocin 125mg x 5mL SUSP / 450ml (Jagsonpal Pharmaceuticals Ltd)$ 1.20
Chlorocin 125mg x 5mL SUSP / 60ml (Jagsonpal Pharmaceuticals Ltd)$ 0.28
250 mg x 10's (Jagsonpal Pharmaceuticals Ltd)$ 0.24

References

  1. DailyMed. "CHLORAMPHENICOL: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "chloramphenicol". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. DrugBank. "chloramphenicol". http://www.drugbank.ca/drugs/DB00446 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Chlornicol are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Chlornicol. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


1 consumer reported age

Users%
30-451
100.0%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 16 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved